ロード中...
PD-L1 Expression Is Associated with Deficient Mismatch Repair and Poor Prognosis in Middle Eastern Colorectal Cancers
Several clinical trials are investigating the use of immune-targeted therapy with Programmed death ligand-1 (PD-L1) inhibitors for colorectal cancer (CRC), with promising results for patients with mismatch repair (MMR) deficiency or metastatic CRC. However, the prognostic significance of PD-L1 expre...
保存先:
| 出版年: | J Pers Med |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911042/ https://ncbi.nlm.nih.gov/pubmed/33530623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11020073 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|